Change in diastolic left ventricular filling after one year of antihypertensive treatment: The losartan intervention for endpoint reduction in hypertension (LIFE) study

Circulation

Volumn 105, Issue 9, 2002, Pages 1071-1076

  Wachtell, Kristian ^a   Bella, Jonathan N ^a   Rokkedal, Jens ^a   Palmieri, Vittorio ^a   Papademetriou, Vasilios ^a   Dahlöf, Björn ^a   Aalto, Tapio ^a   Gerdts, Eva ^a   Devereux, Richard B ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Blood pressure; Diastole; Hypertension; Ventricles

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; LOSARTAN;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAM; HEART LEFT ATRIUM PRESSURE; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

AGED; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD PRESSURE; DIASTOLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LOSARTAN; MALE; MULTIVARIATE ANALYSIS; REMISSION INDUCTION; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 0037022929     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc0902.104599     Document Type: Article

References (33)

1. The progression from hypertension to congestive heart failure
2. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: Prevalence and mortality in a population-based cohort
3. Prevalence, clinical features and prognosis of diastolic heart failure: An epidemiologic perspective
4. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study)
5. Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease
6. Regression of left ventricular hypertrophy in experimental renovascular hypertension: Diastolic dysfunction depends more on myocardial collagen than it does on myocardial mass
7. Lack of effect of short-term lisinopril administration on left ventricular filling dynamics in hypertensive patients with diastolic dysfunction
8. Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension
9. Effects of long-term treatment with prazosin on left ventricular diastolic function in mild to moderate hypertension
10. Left ventricular muscle mass and diastolic function in patients with essential hypertension under long-term clonidine monotherapy
11. Left ventricular systolic and diastolic function and mass before and after antihypertensive treatment in patients with essential hypertension
12. Left ventricular diastolic function in hypertension: A 4 year follow-up study
13. The short-term effects of cilazapril on left ventricular diastolic function
14. Age-dependent event rate and reduction of coronary risk in hypertensive patients with LVH: The LIFE study
15. Relations of aortic root size to left ventricular geometry and function in hypertensive patients with left ventricular hypertrophy: The LIFE Study
16. Antihypertensive treatment in hypertensive patiems with normal left ventricular mass is associated with left ventricular remodeling and improved diastolic function
17. Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling
18. Characteristics of 9194 patients with left ventricular hypertrophy: The LIFE study
19. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: The LIFE study
20. Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study
21. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
22. Reliable estimation of peak left ventricular systolic pressure by M-mode echographic-determined end-diastolic relative wall thickness: Identification of severe valvular aortic stenosis in adult patients
23. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial)
24. Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults
25. Reliability of echocardiographic assessment of left ventricular structure and function: The PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement
26. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure
27. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant pre-diabetic stage of a type II diabetic rat model
28. Treatment of hypertension with perindopril reduces plasma atrial natriuretic peptide levels, left ventricular mass, and improves echocardiographic parameters of diastolic function
29. Normalization of diastolic dysfunction in aortic stenosis late after valve replacement
30. Estimation of left ventricular operating stiffness from Doppler early filling deceleration time in humans
31. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials
32. Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy
33. Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study: Losartan Intervention For Endpoint Reduction in Hypertension